Marker Therapeutics Statistics

Total Valuation

MRKR has a market cap or net worth of $25.88 million. The enterprise value is $18.08 million.

Market Cap	25.88M
Enterprise Value	18.08M

Important Dates

The next estimated earnings date is Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

MRKR has 8.92 million shares outstanding. The number of shares has increased by 3.75% in one year.

Shares Outstanding	8.92M
Shares Change (YoY)	+3.75%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	12.20%
Owned by Institutions (%)	10.63%
Float	6.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.91
Forward PS	25.37
PB Ratio	2.67
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.92

Current Ratio	5.92
Quick Ratio	5.22
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -71.74% and return on invested capital (ROIC) is -47.82%.

Return on Equity (ROE)	-71.74%
Return on Assets (ROA)	-40.87%
Return on Capital (ROIC)	-47.82%
Revenue Per Employee	$465,929
Profits Per Employee	-$1.30M
Employee Count	8
Asset Turnover	0.22
Inventory Turnover	n/a

Taxes

In the past 12 months, MRKR has paid $3,675 in taxes.

Income Tax	3,675
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.98% in the last 52 weeks. The beta is 1.55, so MRKR's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	-35.98%
50-Day Moving Average	3.64
200-Day Moving Average	4.21
Relative Strength Index (RSI)	44.83
Average Volume (20 Days)	32,707

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MRKR had revenue of $3.73 million and -$10.37 million in losses. Loss per share was -$1.17.

Revenue	3.73M
Gross Profit	-5.85M
Operating Income	-10.99M
Pretax Income	-5.66M
Net Income	-10.37M
EBITDA	n/a
EBIT	-10.99M
Loss Per Share	-$1.17

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	7.80M
Total Debt	n/a
Net Cash	7.80M
Net Cash Per Share	$0.87
Equity (Book Value)	9.70M
Book Value Per Share	1.09
Working Capital	9.70M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.90M
Capital Expenditures	n/a
Free Cash Flow	-10.90M
FCF Per Share	-$1.22

Full Cash Flow Statement

Margins

Gross margin is -156.82%, with operating and profit margins of -294.97% and -278.22%.

Gross Margin	-156.82%
Operating Margin	-294.97%
Pretax Margin	-276.43%
Profit Margin	-278.22%
EBITDA Margin	n/a
EBIT Margin	-294.97%
FCF Margin	-429.89%

Dividends & Yields

MRKR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.75%
Shareholder Yield	-3.75%
Earnings Yield	-40.08%
FCF Yield	-42.12%

Analyst Forecast

The average price target for MRKR is $11.00, which is 279.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.00
Price Target Difference	279.31%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	49.20%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 27, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jan 27, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

MRKR has an Altman Z-Score of -42.8 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-42.8
Piotroski F-Score	2